Trial Details
COMPLETEDBasic Information
| Clinical ID | c1444 |
|---|---|
| Identifier | NCT01831427 |
| Trial Title | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Andecaliximab|DRUG: Placebo to match Andecaliximab |
Participant Information
| Sponsor | Gilead Sciences |
|---|---|
| City | Monroe |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2013-03-28 |
|---|---|
| Primary Completion Date | 2015-01-05 |
| Completion Date | 2015-02-06 |